Oceania

The big IP stories you’ll be reading about in 2021

The IAM editorial team identifies what could be this year’s pivotal developments in the global IP market

The big IP stories you’ll be reading about in 2021
Australian vaccine patent ruling shows tough new support requirements for life sciences innovators
8 Dec 2020

Australian vaccine patent ruling shows tough new support requirements for life sciences innovators

Wyeth’s dispute with MSD underscores move towards stricter, UK-style disclosure obligations for IP rights

Australian Federal Court weighs in for the first time on new claim support provision
12 Nov 2020

Australian Federal Court weighs in for the first time on new claim support provision

Latest decision underscores the significance of changes to the country’s Patents Act

Latest

View all
28 Oct 2020

Help us to identify the world's leading IP strategists

The research process for the IAM Strategy 300 2021 is now underway and we are inviting nominations as we decide who should be included Read more

12 Oct 2020

What world class IP management looks like

On top of high-quality, day-to-day performance in areas such as prosecution, litigation and licensing, there are three essential elements an in-house function requires to be part of the elite Read more

9 Sep 2020

The top 10 takeaways from this year’s Global Innovation Index

The latest edition of the annual WIPO publication reveals that Europe and North America still lead despite rising innovation levels in Asia Read more

19 Jun 2020

The advantages and disadvantages of WIPO PROOF

The World Intellectual Property Organization rolled out its new timestamping solution in May and while it has a lot going for it, there are downsides too Read more

Designs

View all
26 Mar 2020

Final call to take part in this year’s IAM benchmarking survey

Help us to identify the key trends currently shaping the global IP market Read more

7 Mar 2020

Daren Tang must seize Asia’s first chance to run the global IP system

After a bruising WIPO director-general election process, Singaporean nominee’s first priority should be to build bridges between the US and China Read more

6 Mar 2020

Notice of postponement - IPBC Europe 2020 and IP Risk Management Europe 2020

New dates for both events, which had been scheduled to take place in the last week of March, will be announced as soon as possible Read more

18 Feb 2020

Tell us what you think of the latest developments in the global IP market

IAM's annual IP benchmarking survey opens today Read more

Finance

View all
26 Mar 2020

Final call to take part in this year’s IAM benchmarking survey

Help us to identify the key trends currently shaping the global IP market Read more

18 Mar 2020

Help us map the latest developments in the global IP market

There’s not long left to answer our annual IP benchmarking survey Read more

6 Mar 2020

Notice of postponement - IPBC Europe 2020 and IP Risk Management Europe 2020

New dates for both events, which had been scheduled to take place in the last week of March, will be announced as soon as possible Read more

18 Feb 2020

Tell us what you think of the latest developments in the global IP market

IAM's annual IP benchmarking survey opens today Read more

Frand/SEPS

View all
11 Jun 2020

We name the world's top patent lawyers, attorneys, practices and firms

The 2020 edition of the IAM Patent 1000 features in-depth analysis of the markets in 48 key jurisdictions and is based on thousands of submissions, interviews and client references Read more

1 Apr 2020

From the IAM archive - setting the standard

A look back into our 17-year back catalogue at some of the outstanding content we have published on this vital subject Read more

26 Mar 2020

Final call to take part in this year’s IAM benchmarking survey

Help us to identify the key trends currently shaping the global IP market Read more

18 Mar 2020

Help us map the latest developments in the global IP market

There’s not long left to answer our annual IP benchmarking survey Read more

Law & Policy

View all
11 Jun 2020

We name the world's top patent lawyers, attorneys, practices and firms

The 2020 edition of the IAM Patent 1000 features in-depth analysis of the markets in 48 key jurisdictions and is based on thousands of submissions, interviews and client references Read more

8 Jun 2020

Benchmarking 2020 – Europe holds its lead but honeymoon might be over for USPTO head

Our annual snapshot of the industry keeps the EPO at the top of the big five but suggests that the shine may have come off Andrei Iancu’s reign Read more

21 May 2020

Global calls for compulsory covid-19 patent licensing build

Scrutiny of biopharma innovators’ coronavirus IP strategies will continue to intensify in coming months as concerns mount about access to treatments Read more

9 Apr 2020

World leaders hatch further plans for accessibility of covid-19 IP rights

WHO to establish voluntary patent pool, while Greek Prime Minister calls for EU to buy rights to vaccines and tests Read more

Litigation

View all
11 Jun 2020

We name the world's top patent lawyers, attorneys, practices and firms

The 2020 edition of the IAM Patent 1000 features in-depth analysis of the markets in 48 key jurisdictions and is based on thousands of submissions, interviews and client references Read more

8 Jun 2020

Benchmarking 2020 – Europe holds its lead but honeymoon might be over for USPTO head

Our annual snapshot of the industry keeps the EPO at the top of the big five but suggests that the shine may have come off Andrei Iancu’s reign Read more

9 Apr 2020

World leaders hatch further plans for accessibility of covid-19 IP rights

WHO to establish voluntary patent pool, while Greek Prime Minister calls for EU to buy rights to vaccines and tests Read more

7 Apr 2020

The key covid-19 compulsory licensing developments so far

Several countries have introduced new laws – or have faced calls – to strengthen their ability to bypass patents Read more

Market Developments

View all
18 Jun 2020

Takeda offloads yet more “non-core” assets with other deals likely to follow

The Japanese big pharma continues to divest drug rights to pay down its debt and fund desperately needed innovation Read more

8 Jun 2020

Benchmarking 2020 – Europe holds its lead but honeymoon might be over for USPTO head

Our annual snapshot of the industry keeps the EPO at the top of the big five but suggests that the shine may have come off Andrei Iancu’s reign Read more

21 May 2020

Global calls for compulsory covid-19 patent licensing build

Scrutiny of biopharma innovators’ coronavirus IP strategies will continue to intensify in coming months as concerns mount about access to treatments Read more

8 Apr 2020

From the IAM archive – the decision makers

A selection of some of the exclusive interviews we have run with the indviduals running the world's most important patent offices Read more

Non-Practising Entities

View all
11 Jun 2020

We name the world's top patent lawyers, attorneys, practices and firms

The 2020 edition of the IAM Patent 1000 features in-depth analysis of the markets in 48 key jurisdictions and is based on thousands of submissions, interviews and client references Read more

8 Jun 2020

Benchmarking 2020 – Europe holds its lead but honeymoon might be over for USPTO head

Our annual snapshot of the industry keeps the EPO at the top of the big five but suggests that the shine may have come off Andrei Iancu’s reign Read more

21 May 2020

Global calls for compulsory covid-19 patent licensing build

Scrutiny of biopharma innovators’ coronavirus IP strategies will continue to intensify in coming months as concerns mount about access to treatments Read more

9 Apr 2020

World leaders hatch further plans for accessibility of covid-19 IP rights

WHO to establish voluntary patent pool, while Greek Prime Minister calls for EU to buy rights to vaccines and tests Read more

Patent Pools

View all
18 Jun 2020

Takeda offloads yet more “non-core” assets with other deals likely to follow

The Japanese big pharma continues to divest drug rights to pay down its debt and fund desperately needed innovation Read more

11 Jun 2020

We name the world's top patent lawyers, attorneys, practices and firms

The 2020 edition of the IAM Patent 1000 features in-depth analysis of the markets in 48 key jurisdictions and is based on thousands of submissions, interviews and client references Read more

21 May 2020

Global calls for compulsory covid-19 patent licensing build

Scrutiny of biopharma innovators’ coronavirus IP strategies will continue to intensify in coming months as concerns mount about access to treatments Read more

9 Apr 2020

World leaders hatch further plans for accessibility of covid-19 IP rights

WHO to establish voluntary patent pool, while Greek Prime Minister calls for EU to buy rights to vaccines and tests Read more

Patents Law

View all
18 Jun 2020

Takeda offloads yet more “non-core” assets with other deals likely to follow

The Japanese big pharma continues to divest drug rights to pay down its debt and fund desperately needed innovation Read more

11 Jun 2020

We name the world's top patent lawyers, attorneys, practices and firms

The 2020 edition of the IAM Patent 1000 features in-depth analysis of the markets in 48 key jurisdictions and is based on thousands of submissions, interviews and client references Read more

8 Jun 2020

Benchmarking 2020 – Europe holds its lead but honeymoon might be over for USPTO head

Our annual snapshot of the industry keeps the EPO at the top of the big five but suggests that the shine may have come off Andrei Iancu’s reign Read more

21 May 2020

Global calls for compulsory covid-19 patent licensing build

Scrutiny of biopharma innovators’ coronavirus IP strategies will continue to intensify in coming months as concerns mount about access to treatments Read more

Strategy

View all
18 Jun 2020

Takeda offloads yet more “non-core” assets with other deals likely to follow

The Japanese big pharma continues to divest drug rights to pay down its debt and fund desperately needed innovation Read more

11 Jun 2020

We name the world's top patent lawyers, attorneys, practices and firms

The 2020 edition of the IAM Patent 1000 features in-depth analysis of the markets in 48 key jurisdictions and is based on thousands of submissions, interviews and client references Read more

21 May 2020

Global calls for compulsory covid-19 patent licensing build

Scrutiny of biopharma innovators’ coronavirus IP strategies will continue to intensify in coming months as concerns mount about access to treatments Read more

17 Apr 2020

Johnson & Johnson, Gilead and Roche are the world’s antiviral patent leaders

A covid-19 vaccine could be produced by anyone, but only a few major players had been actively strengthening and building their portfolios before the pandemic struck Read more

Technology Licensing

View all
18 Jun 2020

Takeda offloads yet more “non-core” assets with other deals likely to follow

The Japanese big pharma continues to divest drug rights to pay down its debt and fund desperately needed innovation Read more

11 Jun 2020

We name the world's top patent lawyers, attorneys, practices and firms

The 2020 edition of the IAM Patent 1000 features in-depth analysis of the markets in 48 key jurisdictions and is based on thousands of submissions, interviews and client references Read more

21 May 2020

Global calls for compulsory covid-19 patent licensing build

Scrutiny of biopharma innovators’ coronavirus IP strategies will continue to intensify in coming months as concerns mount about access to treatments Read more

17 Apr 2020

Johnson & Johnson, Gilead and Roche are the world’s antiviral patent leaders

A covid-19 vaccine could be produced by anyone, but only a few major players had been actively strengthening and building their portfolios before the pandemic struck Read more

Trade Secrets

View all
18 Jun 2020

Takeda offloads yet more “non-core” assets with other deals likely to follow

The Japanese big pharma continues to divest drug rights to pay down its debt and fund desperately needed innovation Read more

21 May 2020

Global calls for compulsory covid-19 patent licensing build

Scrutiny of biopharma innovators’ coronavirus IP strategies will continue to intensify in coming months as concerns mount about access to treatments Read more

7 Apr 2020

The key covid-19 compulsory licensing developments so far

Several countries have introduced new laws – or have faced calls – to strengthen their ability to bypass patents Read more

26 Mar 2020

Final call to take part in this year’s IAM benchmarking survey

Help us to identify the key trends currently shaping the global IP market Read more

Valuation

View all
18 Jun 2020

Takeda offloads yet more “non-core” assets with other deals likely to follow

The Japanese big pharma continues to divest drug rights to pay down its debt and fund desperately needed innovation Read more

21 May 2020

Global calls for compulsory covid-19 patent licensing build

Scrutiny of biopharma innovators’ coronavirus IP strategies will continue to intensify in coming months as concerns mount about access to treatments Read more

9 Apr 2020

World leaders hatch further plans for accessibility of covid-19 IP rights

WHO to establish voluntary patent pool, while Greek Prime Minister calls for EU to buy rights to vaccines and tests Read more

3 Apr 2020

Patent deep-dive shows IBM and Microsoft have cloud computing upper hand

The market is quickly growing and data indicates that the playing field may begin to shift Read more

Find an expert

Anders Sandgaard
Partner
Frederiksberg, Denmark
Aera